Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity.

Saved in:
Bibliographic Details
Title: Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity.
Authors: Pilzer D; Department of Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel., Saar M, Koya K, Fishelson Z
Source: International journal of cancer [Int J Cancer] 2010 Mar 15; Vol. 126 (6), pp. 1428-35.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-0215
DOI:10.1002/ijc.24888